Soluble Therapeutics: Soluble Therapeutics receives $150K NIH grant to extend tech capabilities

Birmingham-based biotech company Soluble Therapeutics was recently awarded a $150,000 grant from the National Institutes of Health in collaboration with the University of Alabama at Birmingham for further research on its flagship technology. The grant will help extend the use of Soluble's HSC technology, which is used for protein formulation, to an important class of protein drug targets called integral membrane proteins, or IMPs. IMPs could play a role in providing unmet medical needs for a variety...